Differences in Regression Patterns of Complete and Incomplete Intestinal Metaplasia at Ten Years after Helicobacter pylori Eradication

被引:3
|
作者
Wada, Yasuhiro [1 ]
Kodama, Masaaki [1 ,2 ]
Mizukami, Kazuhiro [1 ]
Okimoto, Tadayoshi [1 ]
Fuchino, Takafumi [1 ]
Tsutsumi, Koshiro [1 ]
Fukuda, Masahide [1 ]
Hirashita, Yuka [1 ]
Fukuda, Kensuke [1 ]
Okamoto, Kazuhisa [1 ]
Ogawa, Ryo [1 ]
Kushima, Ryoji [3 ]
Murakami, Kazunari [1 ]
机构
[1] Oita Univ, Fac Med, Dept Gastroenterol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan
[2] Oita Univ, Fac Welf & Hlth Sci, Oita, Japan
[3] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga, Japan
关键词
intestinal metaplasia; Helicobacter pylori; gastric cancer; GASTRIC-CANCER; FOLLOW-UP; ENDOSCOPIC RESECTION; ATROPHIC GASTRITIS; EXPRESSION; INFECTION; ADENOCARCINOMA; HISTOGENESIS; POPULATION; PREVENTION;
D O I
10.1267/ahc.21-00069
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study was conducted to reveal the reversibility of subtype of intestinal metaplasia (IM) and Paneth cells after H. pylori eradication (HPE). Among 75 patients, we retrospectively examined the proportions of patients with complete type of IM (CIM), incomplete type of IM (IIM) and Paneth cells in their biopsy specimens obtained from the greater curvature of the antrum (A2) and the greater curvature of the middle corpus (B2) before and during a follow-up period of 10 years after HPE. Immunohistochemistry was used to determine IM type. Compared to before HPE, the proportion of patients with CIM did not decrease significantly during the 10-year follow-up after HPE both in A2 (32% vs. 21.3%, P = 0.13) and in B2 (6.7% vs. 2.7%, P = 0.60). IIM rates in A2 was significantly lower during this time (26.7% vs. 10.7%, P = 0.04), whereas no patients showed IIM in B2 before HPE. The proportion of patients with Paneth cells decreased significantly in A2 after 3, 8, and 9 years of HPE and in B2 after 4, 6 and 9 years of HPE (P < 0.05 for all). Thus, IIM and Paneth cells regressed during a period of 10 years after HPE.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 50 条
  • [31] Regression of cap polyposis after eradication of helicobacter pylori
    Lee, Seong Dae
    Choi, Yong Sung
    Lee, Suk Hee
    Youk, Eui Gon
    Kim, Do Sun
    Lee, Doo Han
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 86 - 86
  • [32] Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori
    Gasbarrini, A
    Franceschi, F
    Tartaglione, R
    Landolfi, R
    Pola, P
    Gasbarrini, G
    LANCET, 1998, 352 (9131): : 878 - 878
  • [33] Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia
    Watari, Jiro
    Das, Koushik K.
    Amenta, Peter S.
    Tanabe, Hiroki
    Tanaka, Atsumi
    Geng, An
    Lin, Jim J. -C.
    Kohgo, Yutaka
    Das, Kiron M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (04) : 409 - 417
  • [34] Regression of Autoimmune Gastritis after Eradication of Helicobacter pylori
    Kotera, Tohru
    Nishimi, Yurika
    Kushima, Ryoji
    Haruma, Ken
    CASE REPORTS IN GASTROENTEROLOGY, 2023, 17 (01) : 34 - 40
  • [35] The effects of Helicobacter pylori eradication on the evolution of chronic atrophic gastritis and intestinal metaplasia
    Bersani, G
    Rossi, A
    Ricci, G
    Pollino, V
    Santilli, F
    Suzzi, A
    De Fabritiis, G
    Alvisi, V
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (05) : AB102 - AB102
  • [36] Eradication of Helicobacter pylori reverses intestinal metaplasia in patients with severe atrophic gastritis
    Haruma, K
    Mihara, M
    Kamada, T
    Kiyohira, K
    Goto, T
    Kido, S
    Hattori, N
    Tani, H
    Tsuga, K
    Kitadai, Y
    Tanaka, S
    Yoshihara, M
    Sumii, K
    Kajiyama, G
    GASTROENTEROLOGY, 1997, 112 (04) : A142 - A142
  • [37] Change of intestinal metaplasia after Helicobacter pylori eradication:: Assessment according to the Updated Sydney System.
    Satoh, K
    Kimura, K
    Kihira, K
    Takimoto, T
    Tokumaru, K
    GASTROENTEROLOGY, 1998, 114 (04) : A278 - A278
  • [38] A pilot trial with celecoxib usage to control the residual gastric intestinal metaplasia after Helicobacter pylori eradication
    Hung, K. H.
    Sheu, B. -S.
    Su, L. -J.
    Yang, H. -B.
    Wu, J. -J.
    HELICOBACTER, 2006, 11 : 47 - 47
  • [39] Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication
    Shichijo, Satoki
    Hirata, Yoshihiro
    Niikura, Ryota
    Hayakawa, Yoku
    Yamada, Atsuo
    Ushiku, Tetsuo
    Fukayama, Masashi
    Koike, Kazuhiko
    GASTROINTESTINAL ENDOSCOPY, 2016, 84 (04) : 618 - 624
  • [40] Histological Intestinal Metaplasia and Endoscopic Atrophy Are Predictors of Gastric Cancer Development After Helicobacter pylori Eradication
    Shichijo, Satoki
    Hirata, Yoshihiro
    Yoshida, Shuntaro
    Yamada, Atsuo
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2015, 148 (04) : S563 - S564